Korea Biomedicine Industry Association

What Korea Biomedicine Industry Association does

The Korea Biomedicine Industry Association (한국바이오의약품협회, KoBIA) is a Seoul-based non-profit industry association that functions as the central coordinating body for South Korea's biopharmaceutical sector. Founded in 2011 with a small staff of 8 employees, KoBIA serves Korean biopharmaceutical manufacturers, biotech firms, and government regulatory bodies (notably the Ministry of Food and Drug Safety / MFDS), providing regulatory intelligence, clinical trial monitoring, policy advocacy, training programs, and overseas market-entry support. The association operates as an independent incorporated association (사단법인) under Korean law and is member-driven rather than investor-backed.

KoBIA's core product portfolio is organized around a portfolio of member-facing information services delivered primarily through its kobia.kr website and member portal. Flagship publications include the monthly "Click! Global Biopharmaceutical Information" newsletter (co-developed with MFDS), the quarterly "Regulatory On-Air" publication covering overseas biopharma legislation, and "Global Bio Insight+" focused on New Approach Methodologies (NAMs). Operational services include "Dynamic BIO" — a member collaboration platform with notice boards, meeting scheduling, opinion exchange, and a resource library — plus weekly domestic and international clinical-trial status reports sourced from MFDS's drug safety system and ClinicalTrials.gov, and monthly biologics approval tracking across MFDS, FDA, EC, and PMDA. KoBIA Brief and KoBIA Insight provide analytical briefings on biosimilar policy, gene/cell/RNA therapy trends, NAMs regulation, and Pharma 5.0 AI-based manufacturing regulation. The association also runs seminars, GMP training programs, AI capability-building courses, and the annual Global Bio Conference in partnership with organizations including Merck, Thermo Fisher Scientific Korea, ProBio, and Korea Health Welfare Human Resources Institute.

KoBIA's revenue mechanics are typical of an industry association: funding derives from undisclosed membership fees, publicly funded project grants (notably the MFDS 2026 overseas expansion support initiative that produced the Click! newsletter), and event/training fees. Pricing is not publicly disclosed. Strategic positioning centers on regulatory coordination with MFDS, the Ministry of Health and Welfare (MOHW), and the Korea National Enterprise for Clinical Trials (KoNECT), as well as participation in the K-Organoid Consortium promoting NAMs and Microphysiological Systems (MPS) technologies at international forums including MPS World Summit 2026.

Name

Korea Biomedicine Industry Association

Legal name

한국바이오의약품협회

Website

https://kobia.kr

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Korea Biomedicine Industry Association (KoBIA) is a Seoul-based non-profit industry association serving Korean biopharmaceutical companies and government regulators with regulatory intelligence, clinical-trial monitoring, policy advocacy, training programs, and overseas market-entry support via its website and member portal.

Ownership category

akta.pro rank

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Distribution channels1 record

Marketing channels6 records

Core offering

Korea Biomedicine Industry Association (KoBIA) is a non-profit incorporated industry association serving as the central hub for the Korean biopharmaceutical sector. It provides member-facing regulatory intelligence publications (Click! Global Biopharmaceutical Information, Regulatory On-Air, Global Bio Insight+, KoBIA Brief, KoBIA Newsletter), weekly/monthly clinical trial and biologics approval status tracking, an industry trend service, a member collaboration platform (Dynamic BIO), a digital resource library, and education/event programs covering GMP, regulatory science, and biomanufacturing.

Product overview

The Korea Biomedicine Industry Association (한국바이오의약품협회, KoBIA) is a non-profit industry association serving as the central hub for the K-bio industry. It does not offer a unified software platform or product suite. Instead, it provides a portfolio of member-facing information services organized under named programs: (1) 'Click! 글로벌 바이오의약품 정보' — a monthly newsletter and Global Bio Insight+ periodical providing global biologics regulatory intelligence in collaboration with MFDS; (2) '바이오의약품 Regulatory On-Air' — a quarterly regulatory publication covering overseas legislation and guideline updates; (3) 'Dynamic BIO' — a member collaboration platform offering notices, meeting scheduling, opinion exchange, and a document repository; (4) 'KoBIA Brief' — an analytical briefing series covering biosimilar policy, global pharma investment, gene/cell/RNA therapy trends, and NAMs regulation; (5) '국내/해외 바이오의약품 임상 및 허가 현황' — weekly and monthly clinical trial and approval status tracking reports from domestic (의약품안전나라) and overseas (ClinicalTrials.gov, FDA, EC, PMDA) sources; (6) '업계동향' — a four-category industry trend service covering legislation, insurance policy, clinical/approval updates, and global trends; (7) '교육 및 행사' — a catalog of seminars, conferences, and training programs co-organized with industry partners; (8) '협회자료실' — a digital library of reports, briefs, and training materials; and (9) 'KoBIA Newsletter' — bilingual association newsletters. The portfolio is delivered through the association's website (kobia.kr) to member companies and the public.

Differentiator

Problem solved

Functional benefit

Brands

• Global Bio Insight+: 정기기간 발간되는 해외 바이오의약품 규제 동향 및 최신 기술 정보 제공 소식지
• 바이오의약품 Regulatory On-Air
• Click! 글로벌 바이오의약품 정보
• KoBIA Brief
• KoBIA Insight
• 글로벌 바이오 콘퍼런스
• Dynamic BIO
• 바이오의약품 해외 규제 전문가 자문 서비스

Products and services

• Click! Global Biopharmaceutical Information (Click! 글로벌 바이오의약품 정보) Monthly bilingual newsletter providing global biopharmaceutical regulatory trends and latest technology information, produced in collaboration with the Ministry of Food and Drug Safety (MFDS) to support overseas market entry by Korean biopharma companies.
• Biopharmaceutical Regulatory On-Air (바이오의약품 Regulatory On-Air) Quarterly publication providing overseas biopharmaceutical legislation and guideline revision/enactment information, covering regulatory developments across the US, EU, China, and Japan.
• Dynamic BIO Member-exclusive collaboration platform offering a notice board, meeting applications, opinion requests, and a document resource library for member companies of the Korea Biomedicine Industry Association.
• KoBIA Brief Analytical briefing series covering topics such as U.S. biosimilar reimbursement policy changes, global Big Pharma K-bio investment trends, gene/cell/RNA therapy data synthesis, bio-health signal analysis, NAMs regulatory adoption, and Pharma 5.0 AI-based manufacturing regulation.
• Domestic/Overseas Biologics Clinical and Approval Status Monitoring Weekly and monthly reports tracking domestic clinical trial statuses (from the Drug Safety Korea system) and overseas clinical trial data (from ClinicalTrials.gov), as well as monthly biologics approval statuses from MFDS, FDA, EC, and PMDA.
• Industry Trend Service (업계동향 서비스) Comprehensive industry trend service covering four categories: legislation/regulation amendments, insurance policy, clinical/approval updates, and global trends. Includes WTO TBT notifications, guideline revisions, and pricing policy updates.
• Education and Events (교육 및 행사) Catalog of seminars, conferences, workshops, and training programs organized in collaboration with organizations such as Merck, Thermo Fisher Scientific Korea, Korea Health Welfare Human Resources Institute, Korea Institute of Regulatory Science, and ProBio. Includes GMP international seminars, AI-based manufacturing/quality management training, and CGT symposiums.
• Association Resource Library (협회자료실) Digital library for members containing reports, briefs, and educational materials organized into three categories: Reports (리포트), Briefs (브리프), and Training Materials (교육자료).
• KoBIA Newsletter (뉴스레터) Bilingual (Korean and English) newsletter series providing association news and industry updates to members, including editions such as No. 125 (English) and No. 706 (Korean).
• Global Bio Insight+ Periodic publication covering overseas biopharmaceutical regulatory trends and latest technology information, with specialization in New Approach Methodologies (NAMs) and next-generation evaluation technologies.

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and supporting.

• 식품의약품안전처 (MFDS / Ministry of Food and Drug Safety)coreStrategic or Co-development Partner · 1 January 2026KoBIA collaborates with MFDS on the 'Click! 글로벌 바이오의약품 정보' (Click! Global Biopharma Information) project, a comprehensive overseas expansion support initiative for Korean biopharma companies. The partnership develops and distributes regulatory intelligence publications, newsletters, and provides advisory services for overseas market entry.
• K-오가노이드 컨소시엄 (K-Organoid Consortium)coreStrategic or Co-development Partner · 1 January 2026KoBIA participates in the K-Organoid Consortium which promotes Korean NAMs (New Approach Methodologies) and MPS (Microphysiological Systems) technologies at international forums such as MPS World Summit 2026, advancing Korea's position in next-generation evaluation technologies.
• 보건복지부 (Ministry of Health and Welfare)coreStrategic or Co-development Partner · 1 January 2026MOHW collaborates with global pharma companies (e.g., Roche, Eli Lilly) on MOU agreements to attract clinical trials and cultivate Korea's biotech ecosystem, with KoBIA coordinating industry participation in these initiatives.
• 국가임상시험지원재단 (KoNECT)coreStrategic or Co-development Partner · 1 January 2026KoBIA partners with KoNECT and MOHW/MFDS to organize the annual KoNECT-MOHW-MFDS International Conference (KIC), bringing together international clinical trial stakeholders.
• 식품의약품안전평가원 (MFDS - 국립의약품안전정보원)supportingTechnology or IntegrationMFDS's Global Regulatory Harmonization Center collaborates with KoBIA on webinars and training programs covering clinical trial regulations and ICH guidelines.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• KoNECT (Korea National Institute for Clinical Trial and Evaluation): Korean clinical trial coordination organization that directly partners with KoBIA on the KoNECT-MOHW-MFDS International Conference. Comparable as a Korean industry-support organization with overlapping membership and government coordination role.
• KoreaBio (Korea Biotechnology Industry Organization): Domestic Korean biotech industry organization providing similar industry coordination, member services, and policy advocacy for Korean biotech companies. Most directly comparable peer given geographic and sector overlap with KoBIA.
• KDRA (Korea Drug Research Association): Korean pharmaceutical industry research association providing R&D and regulatory affairs support to Korean pharma companies. Comparable as a domestic peer with overlapping membership base and regulatory/policy coordination role.
• Korea Pharmaceutical Association (KPA): The Korean pharmacists' and pharmaceutical industry's domestic association with regulatory and policy coordination functions. Comparable as a domestic Korean pharmaceutical sector association, though focused more on pharmacists and pharmacy retail.

Broad incumbents

• IFPMA (International Federation of Pharmaceutical Manufacturers & Associations): Global pharmaceutical industry association coordinating policy and advocacy across national member associations. Comparable as a higher-level industry body, though with international scope versus KoBIA's domestic focus.
• BIO (Biotechnology Innovation Organization): The largest US biotechnology trade association, representing the entire biopharma industry with advocacy, regulatory intelligence, and conference services (BIO Convention). Comparable to KoBIA as a national biopharma industry association serving as the primary industry-government interface.
• PhRMA (Pharmaceutical Research and Manufacturers of America): The US pharmaceutical industry's leading trade association, providing policy advocacy, regulatory engagement with FDA, and member services. Comparable to KoBIA in its role as the coordinating industry voice with government regulators.
• EFPIA (European Federation of Pharmaceutical Industries and Associations): The European pharmaceutical industry's main trade association, providing regulatory affairs support, market intelligence, and policy coordination with EMA. Comparable in function though operating across European markets rather than a single country.

Regional players

• China Pharmaceutical Industry Association (CPIA): Main Chinese pharmaceutical industry trade association providing similar coordination, policy advocacy, and industry intelligence services to Chinese biopharma companies. Comparable in mandate as a national industry body in an Asian biopharma market.
• JPMA (Japan Pharmaceutical Manufacturers Association): The leading Japanese pharmaceutical industry association coordinating with PMDA and Japanese government on regulatory and policy matters. Highly comparable in function and structure as a fellow East Asian national biopharma industry association.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/kobiakor

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Korea Biomedicine Industry Association